Caspofungin Market - Global Industry Analysis

The global Caspofungin market, which accrued nearly 478.96 (USD Million) in 2019, is set to record the CAGR of nearly 0.21% over the period from 2020 to 2026. The report offers assessment and analysis of the Caspofungin market on a global and regional level. The study provides an in-depth assessment of the industry competition, limitations, sales revenues, opportunities, emerging trends, and industry-validated information. The report offers historical data from 2017 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Million).

Introduction

Caspofungin also referred to as Caspofungin acetate is the first kind of anti-fungal medicine of echinocandins class that was launched in 2001. It has received approval from the U.S. FDA for treating adults as well as pediatric patients above age of 3 months. Furthermore, the drug is a new kind of antifungal lipopeptides compound that restricts enzyme beta-1, 3-D-glucan synthase synthesis. Apparently, the enzyme helps in forming of beta 1, 3-glucan polymer that is a key part of cell wall of pathogenic fungi.  Caspofungin is used for treating invasive fungal infections, which are key cause of mortality in hospitalized patients, in the subjects as the drug has proved to be safe and having huge therapeutic potential.

Furthermore, Caspofungin has proved as an effective fungicidal agent against candida species like triazole resisting isolates and has demonstrated triphasic non-linear pharmacokinetics. Reportedly, clinical trials have displayed fungi static activities against aspergillus species. Moreover, the drug possesses short alpha-phase half-life of nearly one to two hours as well as beta-phase half-life of approximately nine to eleven hours that displays log linearity. In addition to this, Caspofungin is inoculated in patients through intravenous route of administration.

Market Growth Dynamics

The drug has proved to be the best therapeutic alternative for treating subjects suffering due to candida infections, aspergillus infections, and candida esophagitis. According to NCBI, the drug has exemplified to be a key anti-fungal agent and exhibited in vitro antifungal activities against Aspergillusfumigatus, C. glabrata, C. tropicalis, A. flavus, C. krusei, and C. parapsilosi. In addition to this, NIH researchers have claimed the efficacy of drugs in animal prototypes of Pneumocystis carinii infection. Apparently, Caspofungin is also used in empirical treatment of patients suffering from febrile neutropenia as well as those with common & serious fungal infections.  All these therapeutic features of the medicine is likely to bolster the growth of the Caspofungin market over the forecast timeline. 

Furthermore, it has also proved to be effective as rescue treatment in treating patients affected due to invasive aspergillosis and treating of oropharyngeal, disseminated, & esophageal candidiasis. Reportedly, the medicine has proved effective in providing treatment to mucosal & invasive candidiasis. Apparently, the drug has beneficial pharmacokinetic features and cannot be metabolized via cytochrome CYP enzyme. This, in turn, will accentuate the expansion of Caspofungin market over the upcoming years. However, harmful effects related to intake of Caspofungin include chills, phlebitis, rash, headache, diarrhea, fever, abdominal pain, nausea, tachycardia, and vomiting. This will hamper the market growth over the estimated timeline. In addition to this, Caspofungin releases histamine in peripheral cells or blood, thereby resulting in creation of histamine- mediated symptoms in patients that can culminate into serious or fatal anaphylaxis.  For the record, the use of the drug is not recommended for pregnant women in the countries like the U.S. This, in turn, can prove detrimental to the growth of the industry over the forecasting timespan.

North American To Establish Leading Position In Market By 2026

The expansion of Caspofungin market in the sub-continent over the forecast timeline can be credited to huge patient population base & presence of key pharmaceutical firms in the countries like the U.S. and Canada. In addition to this, a prominent surge in the aging population in these countries will prop up the growth of Caspofungin business in the North American region over the forecast timespan.   

Key players profiled in the report include Merck & Co., Inc., Mylan N.V., Xellia Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Fresenius SE & Co. KGaA, and Gland Pharma Limited.

The global Caspofungin market is segmented as follows:

By Indication

• Thrush
• Candidiasis

By Distribution Channel

• Online Pharmacies
• Retail Pharmacies
• Hospital Pharmacies

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

• Chapter 1. Preface
  • 1.1. Report Description and Scope
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology
• Chapter 2. Executive Summary
  • 2.1. Caspofungin Market, 2016–2026(USD Million)
  • 2.2. Caspofungin Market: Snapshot
• Chapter 3. Global Caspofungin Market– Industry Analysis
  • 3.1. Caspofungin Market: Market Dynamics
  • 3.2. Market Drivers
    • 3.2.1. The drug has proved to be the best therapeutic alternative for treating subjects suffering due to candida infections, aspergillus infections, and candida esophagitis. Apparently, Caspofungin is also used in empirical treatment of patients suffering from febrile neutropenia as well as those with common & serious fungal infections. All these therapeutic features of the medicine is likely to bulster the growth of the Caspofungin market over the forecast timeline.
    • 3.2.2. The drug has beneficial pharmacokinetic features and cannot be metabulized via cytochrome CYP enzyme. This, in turn, will accentuate the expansion of Caspofungin market over the upcoming years.
  • 3.3. Porter’s Five Forces Analysis
  • 3.4. Market Attractiveness Analysis
    • 3.4.1. Market attractiveness analysis By Indication
    • 3.4.2. Market attractiveness analysis By Distribution Channel
• Chapter 4. Global Caspofungin Market– Competitive Landscape
  • 4.1. Company market share analysis
    • 4.1.1. Global Caspofungin Market: company market share, 2019
  • 4.2. Strategic development
    • 4.2.1. Acquisitions & mergers
    • 4.2.2. New Species launches
    • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
    • 4.2.4. Research and development and Regional expansion
  • 4.3. Price trend analysis
• Chapter 5. Global Caspofungin Market– Indication Analysis
  • 5.1. Global Caspofungin Market overview: By Indication
    • 5.1.1. Global Caspofungin Market share, By Indication, 2019 and 2026
  • 5.2. Thrush
    • 5.2.1. Global Caspofungin Market By Thrush , 2016–2026(USD Million)
  • 5.3. Candidiasis
    • 5.3.1. Global Caspofungin Market By Candidiasis, 2016–2026(USD Million)
• Chapter 6. Global Caspofungin Market– Distribution Channel Analysis
  • 6.1. Global Caspofungin Market overview: By Distribution Channel
    • 6.1.1. Global Caspofungin Market share, By Distribution Channel, 2019 and 2026
  • 6.2. Online Pharmacies
    • 6.2.1. Global Caspofungin Market By Online Pharmacies, 2016–2026(USD Million)
  • 6.3. Retail Pharmacies
    • 6.3.1. Global Caspofungin Market By Retail Pharmacies, 2016–2026(USD Million)
  • 6.4. Hospital Pharmacies
    • 6.4.1. Global Caspofungin Market By Hospital Pharmacies, 2016–2026(USD Million)
• Chapter 7. Company Profiles
  • 7.1. Mylan N.V.
    • 7.1.1. Overview
    • 7.1.2. Financials
    • 7.1.3. Product Portfolio
    • 7.1.4. Business Strategy
    • 7.1.5. Recent Developments
  • 7.2. Teva Pharmaceutical Industries Ltd.
    • 7.2.1. Overview
    • 7.2.2. Financials
    • 7.2.3. Product Portfolio
    • 7.2.4. Business Strategy
    • 7.2.5. Recent Developments
  • 7.3. Fresenius SE & Co. KGaA
    • 7.3.1. Overview
    • 7.3.2. Financials
    • 7.3.3. Product Portfolio
    • 7.3.4. Business Strategy
    • 7.3.5. Recent Developments
  • 7.4. Merck & Co., Inc.
    • 7.4.1. Overview
    • 7.4.2. Financials
    • 7.4.3. Product Portfolio
    • 7.4.4. Business Strategy
    • 7.4.5. Recent Developments
  • 7.5. Xellia Pharmaceuticals
    • 7.5.1. Overview
    • 7.5.2. Financials
    • 7.5.3. Product Portfolio
    • 7.5.4. Business Strategy
    • 7.5.5. Recent Development
  • 7.6. Gland Pharma Limited
    • 7.6.1. Overview
    • 7.6.2. Financials
    • 7.6.3. Product Portfolio
    • 7.6.4. Business Strategy
    • 7.6.5. Recent Development

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global Caspofungin Market, 2016–2026(USD Million)
4. Porter’s Five Forces Analysis
5. Global Caspofungin Market attractiveness, By Indication
6. Global Caspofungin Market attractiveness, By Distribution Channel 
7. Global Caspofungin Market share by Indication ,2019 and 2026 (USD Million)
8. Global Caspofungin Market by Thrush , 2016–2026(USD Million)
9. Global Caspofungin Market by Candidiasis, 2016–2026(USD Million)
10. Global Caspofungin Market share, By Distribution Channel, 2019 and 2026 (USD Million)
11. Global Caspofungin Market by Online Pharmacies, 2016–2026(USD Million)
12. Global Caspofungin Market by Retail Pharmacies,2016–2026(USD Million)
13. Global Caspofungin Market by Hospital Pharmacies,2016–2026(USD Million)
14. Global Caspofungin Market share, by Region, 2019 and 2026
15. North America Caspofungin Market, 2016–2026(USD Million)
16. Europe Caspofungin Market, 2016–2026(USD Million)
17. Asia Pacific Caspofungin Market, 2016–2026(USD Million)
18. Latin America Caspofungin Market, 2016–2026(USD Million)
19. The Middle East and Africa Caspofungin Market, 2016–2026(USD Million)
 

Table Of Tables

List of Tables

1. Global Caspofungin Market: snapshot
2. Drivers of the Caspofungin Market: impact analysis
3. North America Caspofungin Market revenue, By Indication , 2016–2026(USD Million)
4. North America Caspofungin Market revenue, By Distribution Channel , 2016–2026(USD Million)
5. The U.S. Caspofungin Market revenue, By Indication , 2016–2026(USD Million)
6. The U.S. Caspofungin Market revenue, By Distribution Channel, 2016–2026(USD Million)
7. Rest of North America Caspofungin Market revenue, By Indication , 2016–2026(USD Million)
8. Rest of North America Caspofungin Market revenue, By Distribution Channel , 2016–2026(USD Million)
9. Europe Caspofungin Market revenue, By Indication , 2016–2026(USD Million)
10. Europe Caspofungin Market revenue, By Distribution Channel , 2016–2026(USD Million)
11. UK Caspofungin Market revenue, By Indication , 2016–2026(USD Million)
12. UK Caspofungin Market revenue, By Distribution Channel , 2016–2026(USD Million)
13. France Caspofungin Market revenue, By Indication , 2016–2026(USD Million)
14. France Caspofungin Market revenue, By Distribution Channel, 2016–2026(USD Million)
15. Germany Caspofungin Market revenue, By Indication , 2016–2026(USD Million)
16. Germany Caspofungin Market revenue, By Distribution Channel , 2016–2026(USD Million)
17. Rest of Europe Caspofungin Market revenue, By Indication , 2016–2026(USD Million)
18. Rest of Europe Caspofungin Market revenue, By Distribution Channel , 2016–2026(USD Million)
19. Asia Pacific Caspofungin Market revenue, By Indication , 2016–2026(USD Million)
20. Asia Pacific Caspofungin Market revenue, By Distribution Channel, 2016–2026(USD Million)
21. China Caspofungin Market revenue, By Indication , 2016–2026(USD Million)
22. China Caspofungin Market revenue, By Distribution Channel , 2016–2026(USD Million)
23. Japan Caspofungin Market revenue, By Indication, 2016–2026(USD Million)
24. Japan Caspofungin Market revenue, By Distribution Channel, 2016–2026(USD Million)
25. India Caspofungin Market revenue, By Indication , 2016–2026(USD Million)
26. India Caspofungin Market revenue, By Distribution Channel , 2016–2026(USD Million)
27. Rest of Asia Pacific Caspofungin Market revenue, By Indication, 2016–2026(USD Million)
28. Rest of Asia Pacific Caspofungin Market revenue, By Distribution Channel, 2016–2026(USD Million)
29. Latin America Caspofungin Market revenue, By Indication , 2016–2026(USD Million)
30. Latin America Caspofungin Market revenue, By Distribution Channel, 2016–2026(USD Million)
31. Brazil Caspofungin Market revenue, By Indication , 2016–2026(USD Million)
32. Brazil Caspofungin Market revenue, By Distribution Channel, 2016–2026(USD Million)
33. Rest of Latin America Caspofungin Market revenue, By Indication, 2016–2026(USD Million)
34. Rest of Latin America Caspofungin Market revenue, By Distribution Channel, 2016–2026(USD Million)
35. The Middle East and Africa Caspofungin Market revenue, By Indication , 2016–2026(USD Million)
36. The Middle East and Africa Caspofungin Market revenue, By Distribution Channel , 2016–2026(USD Million)
37. Saudi Arabia Caspofungin Market revenue, By Indication , 2016–2026(USD Million)
38. Saudi Arabia Caspofungin Market revenue, By Distribution Channel , 2016–2026(USD Million)
39. South Africa Caspofungin Market revenue, By Indication , 2016–2026(USD Million)
40. South Africa Caspofungin Market revenue, By Distribution Channel , 2016–2026(USD Million)
41. Rest of the Middle East & Africa Caspofungin Market revenue, By Indication , 2016–2026(USD Million)
42. Rest of the Middle East & Africa Caspofungin Market revenue, By Distribution Channel , 2016–2026(USD Million)